Pharmaceuticals, Biotechnology and Life Sciences
Amgen’s Phase 3b study called Liberty, in co-development with Novartis, aimed to test Aimovig for treating migraine, has met it’s…
Alexion Pharmaceuticals has welcomed Deborah Dunsire, M.D. as the company’s Board of Directors new independent director.
Arena Pharmaceuticals ARNA), today announced that it will host a key opinion leader (KOL) event for investors focused on sphingosine-1-phosphate…
Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…
Silence Therapeutics strengthen the protection for its innovative chemical modification technology in Europe, as the European Patent Office granted it…
Celgene Corporation will acquire Juno Therapeutics, it has been announced as the two companies have signed a merger agreement.
In addition to today’s news about Yervoy in combination with Opdivo , Bristol-Myers Squibb said today that the European Commission (EC) has…
Bristol-Myers Squibb Company today said that new data from a cohort of the phase 2 CheckMate -142 test of the…
Sanofi will buy Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, for $11,6…
Bavarian Nordic said Friday that it has kicked off a clinical trial of BN-Brachyury, a novel cancer immunotherapy candidate designed…